…fective allogeneic platform for CAR-based immunotherapy in both cancer and autoimmune diseases, providing a strong foundation for furt…
All extracted diseases
Showing 61–120 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Articles mentioning diseases
23,712 articles · page 220 of 1976….0002). A double-blind, randomized, placebo-controlled trial in COVID-19 patients14 demonstrated that NP-101 led to a faster decline in …
…y pretreated patients across multiple tumor types, particularly HNSCC, with a manageable safety profile. Therefore, exploring the com…
…Background Acute myeloid leukemia (AML) accounts for 25% of acute leukemias in children and 33% i…
…nowledge and competence (K/C) related to choosing patients with BCC who should receive systemic therapies, including IOs. We used a…
…ne checkpoint inhibitors (ICIs) have revolutionized therapy for metastatic melanoma, substantially improving survival outcomes. 1 2 However, as ICI…
… FOXP3+CD25+CD127– Treg cells in colorectal cancer.KRAS-mutated colorectal cancer (CRC) tumors exhibited significantly higher frequencies of both…
…Background Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Recent cl…
…cell-cell interactions among a cohort of primary breast cancer, head and neck squamous cell carcinoma, non-small cell lung cancer, and RCC specimens. Putative tumor …
…, Cohen S. Genetic factors associated with clinical response in melanoma patients treated with talimogene laherparapvec: a single-instit…
… may serve as a novel immunoregulatory marker in the irradiated glioblastoma tumor microenvironment. Ongoing studies will determine whether …
…decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia. Blood. 2016. PMID: 26796361; PMCID: PMC4817311.Esposito CL, Au…